These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30036523)

  • 21. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
    Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
    Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
    Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
    J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection.
    Zhang Z; Wang G; Kang K; Wu G; Wang P
    PLoS One; 2016; 11(4):e0152757. PubMed ID: 27050531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis.
    Wang H; Wang J; Xia J; Yan X; Feng Y; Li L; Chen J; Liu D; Ding W; Yang Y; Huang R; Wu C
    Medicine (Baltimore); 2020 Aug; 99(34):e21408. PubMed ID: 32846758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis Scores: How Much Do Routine Blood Tests Tell About Liver Fibrosis in Chronic Hepatitis C?
    Thandassery RB; Al Kaabi S; Soofi ME; Mohiuddin SA; John AK; Al Mohannadi M; Al Ejji K; Yakoob R; Derbala MF; Wani H; Sharma M; Al Dweik N; Butt MT; Kamel YM; Sultan K; Pasic F; Singh R
    J Clin Gastroenterol; 2016 Jul; 50(6):518-23. PubMed ID: 26974762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FibroScan, aspartate aminotransferase and alanine aminotransferase ratio (AAR), aspartate aminotransferase to platelet ratio index (APRI), fibrosis index based on the 4 factor (FIB-4), and their combinations in the assessment of liver fibrosis in patients with hepatitis B.
    Ding D; Li H; Liu P; Chen L; Kang J; Zhang Y; Ma D; Chen Y; Luo J; Meng Z
    Int J Clin Exp Med; 2015; 8(11):20876-82. PubMed ID: 26885013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
    Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
    J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
    Kim BK; Kim DY; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Han KH
    Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red cell distribution width-to-lymphocyte ratio: A novel predictor for HBV-related liver cirrhosis.
    Zhang X; Wang D; Chen Z; Guo N; Wang W; Xiong C; Liu J; Yue Y; Sun M
    Medicine (Baltimore); 2020 Jun; 99(23):e20638. PubMed ID: 32502047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FibroQ: an easy and useful noninvasive test for predicting liver fibrosis in patients with chronic viral hepatitis.
    Hsieh YY; Tung SY; Lee IL; Lee K; Shen CH; Wei KL; Chang TS; Chuang CS; Wu CS; Lin YH
    Chang Gung Med J; 2009; 32(6):614-22. PubMed ID: 20035640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
    Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
    Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
    Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
    Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
    Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
    [No Abstract]   [Full Text] [Related]  

  • 38. GPR, King's Score and S-Index are superior to other non-invasive fibrosis markers in predicting the liver fibrosis in chronic Hepatitis B patients.
    Ekin N; Ucmak F; Ebik B; Tugba Tuncel E; Kacmaz H; Arpa M; Engin Atay A
    Acta Gastroenterol Belg; 2022; 85(1):62-68. PubMed ID: 35304995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red blood cell distribution width for predicting significant liver inflammation in patients with autoimmune hepatitis.
    Wang H; Wang J; Huang R; Xia J; Zuo L; Yan X; Yang Y; Wu C
    Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1527-1532. PubMed ID: 31107736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy.
    Mada PK; Malus ME; Saldaña Koppel DA; Adley S; Moore M; Alam MJ; Feldman M
    Cureus; 2020 Sep; 12(9):e10376. PubMed ID: 33062499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.